CANY
MEDP icon

Caxton Associates (New York)’s Medpace MEDP Stock Holding History

Caxton Associates (New York)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,873
Closed -$1.6M – 604
2024
Q2 		$1.6M Sell
3,873
-94
-2% -$37.2K 0.05% 188
2024
Q1 		$1.6M Buy
3,967
+2,840
+252% +$999K 0.09% 158
2023
Q4 		$345K Buy
+1,127
New +$304K 0.02% 378
2023
Q2 		– Sell
-1,911
Closed -$359K – 592
2023
Q1 		$359K Buy
+1,911
New +$395K 0.05% 322
2022
Q1 		– Sell
-2,858
Closed -$622K – 630
2021
Q4 		$622K Buy
2,858
+1,735
+154% +$363K 0.06% 219
2021
Q3 		$213K Sell
1,123
-1,678
-60% -$306K 0.02% 392
2021
Q2 		$495K Buy
2,801
+1,128
+67% +$195K 0.05% 175
2021
Q1 		$274K Buy
+1,673
New +$256K 0.02% 304
2020
Q4 		– Sell
-5,171
Closed -$578K – 251
2020
Q3 		$578K Sell
5,171
-1,447
-22% -$167K 0.06% 102
2020
Q2 		$616K Buy
+6,618
New +$563K 0.05% 108
2019
Q2 		– Sell
-4,714
Closed -$278K – 477
2019
Q1 		$278K Buy
+4,714
New +$282K 0.04% 277
2018
Q4 		– Sell
-11,113
Closed -$666K – 405
2018
Q3 		$666K Buy
11,113
+6,182
+125% +$338K 0.05% 191
2018
Q2 		$212K Buy
+4,931
New +$199K 0.01% 348

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caxton Associates (New York)'s MEDP Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Medpace (MEDP) in Q3 2024, closing a stake of 3,873 shares — an estimated $1.6M sold.

Caxton Associates (New York) first reported a position in MEDP in Q2 2018 and held it in 13 quarters. The position peaked at $1.6M in Q1 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,873 Medpace shares in Q3 2024, an estimated $1.6M.
  • Caxton Associates (New York) first reported a position in Medpace in Q2 2018 and held it in 13 quarters.
  • Caxton Associates (New York)'s Medpace position peaked at $1.6M in Q1 2024.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.